Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients
Background microRNAs (miRNAs) have been studied for their role in the early detection of several diseases. However, there is no current information on the systematic screening of serum-derived cisplatin resistance biomarkers in gastric cancer (GC). Methods Cisplatin-resistant GC cell lines were scre...
Main Authors: | Lei Jin, Nan Zhang, Qian Zhang, Guoqian Ding, Zhenghan Yang, Zhongtao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/8943.pdf |
Similar Items
-
High throughput microRNAs sequencing profile of serum exosomes in women with and without polycystic ovarian syndrome
by: Feng Zhang, et al.
Published: (2021-03-01) -
MicroRNAs as Diagnostic Biomarkers in Gastric Cancer
by: Jianmin Si, et al.
Published: (2012-10-01) -
Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
by: Ali Gheysarzadeh, et al.
Published: (2018-01-01) -
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs
by: Hong Liu, et al.
Published: (2019-02-01) -
Serum microRNAs as biomarkers for recurrence in melanoma
by: Friedman Erica B, et al.
Published: (2012-08-01)